financetom
Business
financetom
/
Business
/
Thermo Fisher Scientific Insider Sold Shares Worth $11,374,358, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Thermo Fisher Scientific Insider Sold Shares Worth $11,374,358, According to a Recent SEC Filing
Jun 5, 2024 2:32 PM

05:05 PM EDT, 06/05/2024 (MT Newswires) -- Marc N Casper, Director, Chairman & CEO, on June 03, 2024, sold 20,000 shares in Thermo Fisher Scientific ( TMO ) for $11,374,358. Following the Form 4 filing with the SEC, Casper has control over a total of 183,724 shares of the company, with 123,816 shares held directly and 59,908 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/97745/000112760224017949/xslF345X03/form4.xml

Price: 574.00, Change: -1.28, Percent Change: -0.22

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Zscaler Beats Fourth-Quarter Views; 2025 Earnings Outlook Falls Short
Zscaler Beats Fourth-Quarter Views; 2025 Earnings Outlook Falls Short
Sep 4, 2024
04:37 PM EDT, 09/03/2024 (MT Newswires) -- Zscaler ( ZS ) late Tuesday reported stronger-than-expected fiscal fourth-quarter results, though the cloud security company's 2025 earnings outlook missed Wall Street's estimates. Adjusted per-share earnings jumped to $0.88 during the quarter ended July 31 from $0.64 a year earlier, higher than the consensus on Capital IQ for $0.69. Revenue grew 30% to...
Asana Stock Falls After Q2 Results; Q3, FY Guidance Below Estimates
Asana Stock Falls After Q2 Results; Q3, FY Guidance Below Estimates
Sep 4, 2024
Asana, Inc. ( ASAN ) reported its second-quarter financial results after Tuesday's closing bell. Here's a look at the details from the report.  The Details: Asana reported quarterly losses of five cents per share, which beat the analyst estimate of losses of eight cents per share. Quarterly revenue clocked in at $179.212 million, beating the $177.654 million consensus estimate. Core...
PagerDuty Fiscal Q2 Non-GAAP EPS, Revenue Rise; Fiscal 2025 Revenue Outlook Cut
PagerDuty Fiscal Q2 Non-GAAP EPS, Revenue Rise; Fiscal 2025 Revenue Outlook Cut
Sep 4, 2024
04:34 PM EDT, 09/03/2024 (MT Newswires) -- PagerDuty ( PD ) reported fiscal Q2 non-GAAP net income late Tuesday of $0.21 per diluted share, up from $0.19 per share a year earlier. Analysts polled by Capital IQ expected $0.17. Revenue for the quarter ended July 31 rose to $115.9 million from $107.6 million a year earlier. Analysts surveyed by Capital...
Vaxcyte Starts $1 Billion Underwritten Public Offering
Vaxcyte Starts $1 Billion Underwritten Public Offering
Sep 4, 2024
04:35 PM EDT, 09/03/2024 (MT Newswires) -- Vaxcyte ( PCVX ) said Tuesday it started a $1 billion underwritten public offering of common shares and pre-funded warrants. The company said it plans to give underwriters a 30-day option to buy up to an additional $150 million of common shares, including those underlying the pre-funded warrants. Shares of the company were...
Copyright 2023-2026 - www.financetom.com All Rights Reserved